Atlas Trials

Acquired Blepharophimosis

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acquired Blepharophimosis

RecordFirmDate
LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis. (NCT06514612)Santen SAS2024-12-30

Track Acquired Blepharophimosis automatically

Every clearance here is in the API, with alerts when new ones post.